Claritin 12-Hour Takes Aim At Shorter-Duration Allergy Drugs
This article was originally published in The Tan Sheet
Executive Summary
Schering-Plough extends the Claritin line into the 12-hour allergy relief niche to go after first-generation antihistamines with shorter durations
You may also be interested in...
Claritin, Linens Make Strange Bedfellows But Licensing Revenue For Merck
Merck has a strategy for squeezing more juice out of an OTC brand in an increasingly competitive market segment: out-licensing to non-drug products
Claritin, Linens Make Strange Bedfellows But Licensing Revenue For Merck
Merck has a strategy for squeezing more juice out of an OTC brand in an increasingly competitive market segment: out-licensing to non-drug products
Claritin, Linens Make Strange Bedfellows But Licensing Revenue For Merck
Merck has a strategy for squeezing more juice out of an OTC brand in an increasingly competitive market segment: out-licensing to non-drug products